Related Experiment Video
Updated: Aug 10, 2026
08:02
Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Clinical studies with a new steroid--fluorometholone
Annals of Ophthalmology
|July 1, 1975
Summary
Fluorometholone effectively manages ocular inflammation in uveitis, episcleritis, and allergic conjunctivitis. This steroid alternative shows promise by controlling inflammation without increasing intraocular pressure (IOP).
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Corticosteroids are commonly used to treat ocular inflammation.
- Elevated intraocular pressure (IOP) is a potential side effect of corticosteroid treatment.
- Alternative anti-inflammatory agents with a lower risk of IOP increase are needed.
Purpose of the Study:
- To evaluate the efficacy and safety of fluorometholone in managing ocular inflammation.
- To determine if fluorometholone can control inflammation without causing elevated IOP.
Main Methods:
- Retrospective review of 34 cases of uveitis, 2 cases of episcleritis, and 1 case of allergic conjunctivitis.
- Patients were treated with various steroids, and IOP was monitored.
- Fluorometholone was used as an alternative steroid in cases with elevated IOP.
Main Results:
- 25 out of 34 uveitis patients experienced elevated IOP with conventional steroids.
- Stopping local steroids was necessary to reduce IOP in these cases.
- Fluorometholone demonstrated comparable anti-inflammatory effects to other steroids without increasing IOP in all cases.
Conclusions:
- Fluorometholone appears to be an effective anti-inflammatory agent for uveitis, episcleritis, and allergic conjunctivitis.
- Fluorometholone may be a safer alternative for patients at risk of steroid-induced IOP elevation.
- Further controlled studies are warranted to confirm these preliminary findings.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...